longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

Atrium Therapeutics(RNA.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

Atrium Therapeutics Reports First Quarter 2026 Financial Results | RNA Stock News

StockTitan·05/14/2026 20:40
US
RNA
-1.78%
StockTitan·05/14/2026 20:40
US
RNA
-1.78%

11:44 ETAdvaita Bio představuje iSCanGuide™: Integrovanou analýzu jednobuněčné a prostorové transkriptomiky využívající infrastrukturu s GPU akcelerací

prnewswire·05/08/2026 23:45
US
RNA
-1.78%
US
MBIO
-4.46%
US
SBIO
+3.75%
prnewswire·05/08/2026 23:45
US
RNA
-1.78%
US
MBIO
-4.46%
US
SBIO
+3.75%

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Month

benzinga_article·04/21/2026 18:26
US
KNSA
+1.76%
US
NNOX
+4.62%
US
RNA
-1.78%
benzinga_article·04/21/2026 18:26
US
KNSA
+1.76%
US
NNOX
+4.62%
US
RNA
-1.78%

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | RNA Stock News

StockTitan·04/21/2026 02:50
US
RNA
-1.78%
StockTitan·04/21/2026 02:50
US
RNA
-1.78%
© 2026 Longbridge|Disclaimer

Event Tracking

May15
Atrium Therapeutics released FY2026 Q1 earnings on May 14 (EST), actual revenue USD 19.64 M (forecast USD 2 M), actual EPS USD -0.9723 (forecast USD -1.05)
03:00
Feb24
Atrium Therapeutics released FY2025 earnings on February 23 (EST), actual revenue USD 18.62 M, actual EPS USD -3.1905 (forecast EPS USD -4.4791)
04:00
Atrium Therapeutics released FY2025 Q4 earnings on February 23 (EST), actual revenue USD 859K, actual EPS USD -1.8779
04:00
Feb4
JPMorgan Expresses Concern Over Novartis' Long-Term Prospects
02:09
Dec16
Pharmaceutical Industry M&A Value Up 31% in 2025 to $179.6 Billion
17:43
Nov24
Avidity Biosciences Inc. Special Shareholder Meeting to Vote on Novartis Merger Agreement
22:11

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 19.64 M, Net Income -16.63 M, EPS -0.9723

Feb23
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 859 K, Net Income -29.14 M, EPS -1.8779

Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.48 M, Net Income -174.44 M, EPS -1.265

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
OPTH
6.080
+2,485.03%
+5.845
HCWB
2.430
+129.25%
+1.370
SLXN
0.5298
+96.95%
+0.261
VIDA
4.150
+81.22%
+1.860
GCL
0.7445
+72.46%
+0.313
PHGE
0.5969
+59.60%
+0.223
MTVA
2.890
+53.72%
+1.010
MWC
7.150
+51.48%
+2.430
PETZ
1.150
+41.98%
+0.340
MLGO
5.360
+39.95%
+1.530
View More